Quarterly
Annual
| Unit: USD | 2024-03-31 |
|---|---|
operating expenses | |
research and development | 34,824,000 |
general and administrative | 10,898,000 |
impairment of long-lived assets | 27,347,000 |
total operating expenses | 73,069,000 |
income from operations | -73,069,000 |
yoy | |
qoq | |
operating margin % | |
interest income | 1,995,000 |
other income | -72,000 |
net income | -71,146,000 |
yoy | |
qoq | |
net income margin % | |
unrealized gain on investments | -30,000 |
comprehensive loss | -71,176,000 |
net income per common share: | |
basic and diluted | -810 |
weighted-average number of common shares outstanding: | |
basic and diluted | 88,042,000 |
The information provided in this report is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
